Sign in
Taking people in United StatesNo phase

Clareon TruPlus Study

Key facts

Who runs it
Alcon Research
Where
Brecksville, Mt. Pleasant, Phoenix, Salt Lake City, and Sugar Land, United StatesSee the 5 sites
Trial code
Status
Recruiting
People taking part
185 people, planned
Started
26 May 2026
Expected to end
Jun 2028
Type of study
Interventional
Treatments tested
  • Clareon TruPlus Monofocal Non-Toric IOL
  • Clareon TruPlus Monofocal Toric IOL
  • Phacoemulsification
Record updated
30 October 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Diagnosed with bilateral cataracts and planned bilateral cataract extraction by routine phacoemulsification
  • Potential postoperative BCDVA of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator
  • Astigmatism suitable for correction with available toric IOL models
  • Other protocol-specified inclusion criteria may apply

Who cannot take part

  • Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and other eye conditions as specified in the protocol
  • Moderate to severe dry eye that would affect study measurements
  • Other protocol-specified exclusion criteria may apply

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Aphakia or astigmatism

This trial is currently available in United States.

  • Cleveland Eye ClinicBrecksville, United StatesTaking people
  • Carolina Eyecare Physicians LLCMt. Pleasant, United StatesTaking people
  • Eye Doctors of ArizonaPhoenix, United StatesTaking people
  • The Eye Institute of UtahSalt Lake City, United StatesTaking people
  • Berkeley Eye CenterSugar Land, United StatesTaking people

About the trial

What the trial wants to find out

The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.

The group in the trial

  • Clareon TruPlus Monofocal IOLTreatment being tested

    Implantation with the Clareon TruPlus Monofocal IOL (Non-Toric or Toric) following removal of the clouded natural lens using phacoemulsification

    Treatment: Clareon TruPlus Monofocal Non-Toric IOL, Clareon TruPlus Monofocal Toric IOL, and Phacoemulsification

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clareon TruPlus Single-Arm Study
Criteria questions
Built from NCT07502456, who can take part
Record updated
30 October 2026